PAPER Cui Y, Liu X, Wang M, Liu L, Sun X, Ma L, Xie W, Wang C, Tang S, Wang D, Wu Q
SEARCH RESULTS
330919 RESULTS
PAPER Nakajima A, Ohizumi Y, Yamada K
Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies.
Clin Psychopharmacol Neurosci. 2014 Aug;12(2):75-82. Epub 2014 Aug 12 PubMed: 25191498PAPER Collingwood JF, Davidson MR
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light.
Front Pharmacol. 2014;5:191. Epub 2014 Aug 19 PubMed: 25191270PAPER Qian ZM, Ke Y
Huperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?
Front Aging Neurosci. 2014;6:216. Epub 2014 Aug 19 PubMed: 25191267PAPER D'Alton S, Lewis J
Therapeutic and diagnostic challenges for frontotemporal dementia.
Front Aging Neurosci. 2014;6:204. Epub 2014 Aug 19 PubMed: 25191265PAPER Bosch M, Kielian T
Hemichannels in neurodegenerative diseases: is there a link to pathology?
Front Cell Neurosci. 2014;8:242. Epub 2014 Aug 20 PubMed: 25191227PAPER Fuller JP, Stavenhagen JB, Teeling JL
New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease.
Front Neurosci. 2014;8:235. Epub 2014 Aug 21 PubMed: 25191216PAPER Santra A, Sinha GK, Neogi R, Thukral RK
(99m)Tc-hexamethyl propyleneamine oxime brain perfusion single photon emission computed tomography in characterization of dementia: an initial experience in Indian clinical practice.
World J Nucl Med. 2014 May;13(2):120-7. PubMed: 25191127PAPER Al-Faham Z, Zein RK, Wong CY
18F-FDG PET assessment of Lewy body dementia with cerebellar diaschisis.
J Nucl Med Technol. 2014 Dec;42(4):306-7. Epub 2014 Sep 4 PubMed: 25190733PAPER Chang YL, Chen TF, Shih YC, Chiu MJ, Yan SH, Tseng WY
Regional cingulum disruption, not gray matter atrophy, detects cognitive changes in amnestic mild cognitive impairment subtypes.
J Alzheimers Dis. 2015;44(1):125-38. PubMed: 25190630PAPER Belleville S, Fouquet C, Duchesne S, Collins DL, Hudon C
Detecting early preclinical Alzheimer's disease via cognition, neuropsychiatry, and neuroimaging: qualitative review and recommendations for testing.
J Alzheimers Dis. 2014;42 Suppl 4:S375-82. PubMed: 25190629PAPER Vuorinen M, Spulber G, Damangir S, Niskanen E, Ngandu T, Soininen H, Kivipelto M, Solomon A
Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging.
J Alzheimers Dis. 2015;44(1):93-101. PubMed: 25190628PAPER Mataró M, Soriano-Raya JJ, López-Olóriz J, Miralbell J, Dacosta-Aguayo R
Cerebrovascular markers in lowered cognitive function.
J Alzheimers Dis. 2014;42 Suppl 4:S383-91. PubMed: 25190627PAPER DiTacchio KA, Heinemann SF, Dziewczapolski G
Metformin treatment alters memory function in a mouse model of Alzheimer's disease.
J Alzheimers Dis. 2015;44(1):43-8. PubMed: 25190626PAPER Milner E, Zhou ML, Johnson AW, Vellimana AK, Greenberg JK, Holtzman DM, Han BH, Zipfel GJ
Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice.
Stroke. 2014 Oct;45(10):3064-9. Epub 2014 Sep 4 PubMed: 25190447Current Filters
No filters selected